https://www.amgen.ca/ 2024-11-14 daily 0.5 https://www.amgen.ca/fr-ca 2024-11-12 daily 0.5 https://www.amgen.ca/aranesp-video 2025-01-29 monthly 0.5 https://www.amgen.ca/fr-ca/aranesp-video 2025-01-29 monthly 0.5 https://www.amgen.ca/about 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/about 2024-12-10 daily 0.5 https://www.amgen.ca/science 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science 2024-11-05 daily 0.5 https://www.amgen.ca/therapeutic-areas 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/therapeutic-areas 2024-12-10 daily 0.5 https://www.amgen.ca/responsibility 2026-01-05 daily 0.5 https://www.amgen.ca/fr-ca/responsibility 2026-01-05 daily 0.5 https://www.amgen.ca/nplate-dose-calculator 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/nplate-dose-calculator 2024-11-06 daily 0.5 https://www.amgen.ca/careers 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/careers 2024-11-05 daily 0.5 https://www.amgen.ca/hcp-privacy-statement 2025-06-18 daily 0.5 https://www.amgen.ca/fr-ca/hcp-privacy-statement 2025-06-05 daily 0.5 https://www.amgen.ca/privacy-statement 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/privacy-statement 2024-11-05 daily 0.5 https://www.amgen.ca/terms-of-use 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/terms-of-use 2024-11-05 daily 0.5 https://www.amgen.ca/sitemap 2024-11-04 monthly 0.5 https://www.amgen.ca/fr-ca/sitemap 2024-08-29 monthly 0.5 https://www.amgen.ca/media 2024-11-04 monthly 0.5 https://www.amgen.ca/fr-ca/media 2024-11-05 monthly 0.5 https://www.amgen.ca/stories 2026-02-20 always https://www.amgen.ca/fr-ca/stories 2026-02-20 always https://www.amgen.ca/page-not-found 2025-02-03 daily 0.5 https://www.amgen.ca/fr-ca/page-not-found 2025-02-04 daily 0.5 https://www.amgen.ca/search-results 2025-02-05 daily 0.5 https://www.amgen.ca/fr-ca/search-results 2025-02-05 daily 0.5 https://www.amgen.ca/about/mission-and-values 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/about/mission-and-values 2024-11-05 daily 0.5 https://www.amgen.ca/about/products 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/about/products 2024-11-05 daily 0.5 https://www.amgen.ca/about/transparency 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/about/transparency 2024-11-05 daily 0.5 https://www.amgen.ca/about/contact-us 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/about/contact-us 2024-11-14 daily 0.5 https://www.amgen.ca/about/leadership-team 2024-11-05 daily 0.5 https://www.amgen.ca/fr-ca/about/leadership-team 2024-11-05 daily 0.5 https://www.amgen.ca/about/useful-links 2025-01-08 daily 0.5 https://www.amgen.ca/fr-ca/about/useful-links 2025-01-08 daily 0.5 https://www.amgen.ca/science/biosimilars 2024-09-17 daily 0.5 https://www.amgen.ca/fr-ca/science/biosimilars 2024-11-05 daily 0.5 https://www.amgen.ca/science/biomanufacturing 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/biomanufacturing 2024-11-05 daily 0.5 https://www.amgen.ca/science/biotechnology 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/biotechnology 2024-11-05 daily 0.5 https://www.amgen.ca/science/clinical-trials 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/clinical-trials 2024-11-05 daily 0.5 https://www.amgen.ca/science/innovative-medicines 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/innovative-medicines 2024-11-05 daily 0.5 https://www.amgen.ca/responsibility/environment-social-and-governance-strategy 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/environment-social-and-governance-strategy 2024-09-13 daily 0.5 https://www.amgen.ca/responsibility/amgen-foundation 2026-01-06 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/amgen-foundation 2026-03-10 daily 0.5 https://www.amgen.ca/responsibility/ethics-and-compliance 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/ethics-and-compliance 2024-11-05 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations 2024-10-23 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations 2024-12-13 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations 2024-11-05 daily 0.5 https://www.amgen.ca/responsibility/science-education 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/science-education 2024-11-05 daily 0.5 https://www.amgen.ca/media/press-releases 2024-07-05 monthly 0.5 https://www.amgen.ca/fr-ca/media/press-releases 2024-07-02 monthly 0.5 https://www.amgen.ca/about/products/patient-assistance 2024-09-29 daily 0.5 https://www.amgen.ca/fr-ca/about/products/patient-assistance 2024-09-29 daily 0.5 https://www.amgen.ca/science/biomanufacturing/how-biotechnology-medicines-are-made 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/biomanufacturing/how-biotechnology-medicines-are-made 2024-11-05 daily 0.5 https://www.amgen.ca/science/biotechnology/discovering-and-developing-medicines 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/science/biotechnology/discovering-and-developing-medicines 2024-11-05 daily 0.5 https://www.amgen.ca/science/biotechnology/the-science-of-biotechnology 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/science/biotechnology/the-science-of-biotechnology 2024-11-05 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations/apply-donation-funding-canadian-healthcare-community 2025-01-09 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations/apply-donation-funding-canadian-healthcare-community 2025-01-09 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations/contact-us 2024-12-10 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations/contact-us 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations/error 2025-01-27 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations/error 2025-01-27 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations/faqs 2024-12-10 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations/faqs 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/healthcare-donations/success 2025-01-27 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/healthcare-donations/success 2025-01-27 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/apply-donation-funding-canadian-non-healthcare-community 2026-02-13 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations/apply-donation-funding-canadian-non-healthcare-community 2026-02-13 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/contact-us 2024-12-13 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations/contact-us 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/eligibility-criteria 2024-12-13 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations/eligibility-criteria 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/error 2025-01-27 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/faqs 2024-12-13 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations/faqs 2024-12-13 daily 0.5 https://www.amgen.ca/responsibility/non-healthcare-donations/success 2025-01-27 daily 0.5 https://www.amgen.ca/fr-ca/responsibility/non-healthcare-donations/success 2025-01-27 daily 0.5 https://www.amgen.ca/stories/categories/health-and-wellness 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/health-and-wellness 2022-05-26 monthly 1.0 https://www.amgen.ca/stories/categories/rare-disease 2025-07-29 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/rare-disease 2025-07-29 monthly 1.0 https://www.amgen.ca/stories/categories/bone 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/bone 2023-05-03 monthly 1.0 https://www.amgen.ca/stories/categories/cardiovascular 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/cardiovascular 2023-05-03 monthly 1.0 https://www.amgen.ca/stories/categories/inflammation 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/inflammation 2023-05-03 monthly 1.0 https://www.amgen.ca/stories/categories/oncology 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/oncology 2023-05-03 monthly 1.0 https://www.amgen.ca/stories/categories/responsibility 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/responsibility 2024-11-06 monthly 1.0 https://www.amgen.ca/stories/categories/leadership 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/leadership 2024-11-06 monthly 1.0 https://www.amgen.ca/stories/categories/science-and-innovation 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/science-and-innovation 2022-05-26 monthly 1.0 https://www.amgen.ca/stories/categories/people-and-culture 2024-11-05 monthly 1.0 https://www.amgen.ca/fr-ca/stories/categories/people-and-culture 2022-05-26 monthly 1.0 https://www.amgen.ca/stories/2022/10/amgen-scholars-canada,-d-,-empowering-undergrads-in-stem 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/amgen-scholars-canada,-d-,-empowering-undergrads-in-stem 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/10/bone-health 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/bone-health 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/10/cancer-care 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/cancer-care 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/10/heart-care 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/heart-care 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/10/investing-in-the-future-with-graduate-internships-and-stem-programs 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/investing-in-the-future-with-graduate-internships-and-stem-programs 2025-02-19 daily 0.5 https://www.amgen.ca/stories/2022/10/nurturing-early-stem-education-for-a-diverse-workforce 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/nurturing-early-stem-education-for-a-diverse-workforce 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/10/why-bone-health-and-early-osteoporosis-detection-matters 2025-10-22 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/10/why-bone-health-and-early-osteoporosis-detection-matters 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/08/5-bone-health-questions-to-ask-your-doctor 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/5-bone-health-questions-to-ask-your-doctor 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/a-day-in-the-life 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/a-day-in-the-life 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/ask-expert-qa-aldo-del-col 2025-09-22 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/ask-expert-qa-aldo-del-col 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/at-the-heart-of-the-matter 2024-11-06 daily 0.5 https://www.amgen.ca/stories/2022/08/back-to-normal-get-back-to-bone-health-first 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/back-to-normal-get-back-to-bone-health-first 2024-11-06 daily 0.5 https://www.amgen.ca/stories/2022/08/biologics-what-are-they 2026-01-19 daily 0.5 https://www.amgen.ca/stories/2022/08/biosimilar-medicines-a-complex-new-entrant 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/biosimilars-in-canada 2025-02-19 daily 0.5 https://www.amgen.ca/stories/2022/08/can-bones-hurt 2025-10-31 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/can-bones-hurt 2025-09-11 daily 0.5 https://www.amgen.ca/stories/2022/08/could-rheumatoid-arthritis-steal-your-independence 2025-09-11 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/could-rheumatoid-arthritis-steal-your-independence 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/debunking-common-myths-osteoporosis 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/debunking-common-myths-osteoporosis 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/dont-let-retirement-dreams-be-dashed-assess-your-bone-health-now 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/dont-let-retirement-dreams-be-dashed-assess-your-bone-health-now 2025-10-28 daily 0.5 https://www.amgen.ca/stories/2022/08/fragility-fractures-and-future-dreams 2024-11-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/fragility-fractures-and-future-dreams 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/genetically-engineering-a-cell 2026-01-16 daily 0.5 https://www.amgen.ca/stories/2022/08/having-the-talk-with-your-aging-parents 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/having-the-talk-with-your-aging-parents 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/healthy-bones-dont-break-usually 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/heart-attack-and-stroke-are-you-at-risk 2025-02-25 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/heart-attack-and-stroke-are-you-at-risk 2025-02-25 daily 0.5 https://www.amgen.ca/stories/2022/08/high-cholesterol-here-are-some-ways-to-deal-with-it 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/high-cholesterol-here-are-some-ways-to-deal-with-it 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/how-are-biologic-medicines-different-from-other-drugs 2025-11-06 daily 0.5 https://www.amgen.ca/stories/2022/08/how-well-do-you-know-osteoporosis 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/how-well-do-you-know-osteoporosis 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/ive-been-diagnosed-with-colorectal-cancernow-what 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/living-with-colorectal-cancer-marks-story 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/living-with-colorectal-cancer-marks-story 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/living-with-rheumatoid-arthritis-sadiqs-story 2025-10-28 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/living-with-rheumatoid-arthritis-sadiqs-story 2025-10-28 daily 0.5 https://www.amgen.ca/stories/2022/08/living-with-terminal-cancer 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/living-with-terminal-cancer 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/multiple-myeloma-guide-available-treatments 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/multiple-myeloma-guide-available-treatments 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/multiple-myeloma-ljubicas-story 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/multiple-myeloma-ljubicas-story 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/multiple-myeloma-patient-journey 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/multiple-myeloma-patient-journey 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/never-to-return-home-again 2026-01-16 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/never-to-return-home-again 2026-01-16 daily 0.5 https://www.amgen.ca/stories/2022/08/on-the-future-of-colorectal-cancer-in-canada 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/on-the-future-of-colorectal-cancer-in-canada 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/osteoporosis-dont-leave-it-to-chance 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/patients-need-know-biologics-biosimilars 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/prevention-education-and-advocacy-an-interview-with-the-president-of-colorectal-cancer-canada 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/prevention-education-and-advocacy-an-interview-with-the-president-of-colorectal-cancer-canada 2025-10-23 daily 0.5 https://www.amgen.ca/stories/2022/08/rheumatoid-arthritis-plenty-to-consider 2026-01-12 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/rheumatoid-arthritis-plenty-to-consider 2025-10-27 daily 0.5 https://www.amgen.ca/stories/2022/08/switching-rheumatoid-arthritis-medications-whats-the-big-deal 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/taking-control-of-rheumatoid-arthritis 2025-10-28 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/taking-control-of-rheumatoid-arthritis 2025-10-28 daily 0.5 https://www.amgen.ca/stories/2022/08/talk-to-your-doctor-about-these-bone-thinning-treatments 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/talk-to-your-doctor-about-these-bone-thinning-treatments 2024-11-06 daily 0.5 https://www.amgen.ca/stories/2022/08/the-alarming-facts-about-heart-attack-and-stroke-in-canada 2025-02-19 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/the-alarming-facts-about-heart-attack-and-stroke-in-canada 2025-02-19 daily 0.5 https://www.amgen.ca/stories/2022/08/the-evolution-of-biotechnology 2026-01-16 daily 0.5 https://www.amgen.ca/stories/2022/08/tips-living-multiple-myeloma 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/tips-living-multiple-myeloma 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/08/understanding-bone-mineral-density 2024-11-06 daily 0.5 https://www.amgen.ca/stories/2022/08/understanding-multiple-myeloma 2025-10-27 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/08/understanding-multiple-myeloma 2025-09-10 daily 0.5 https://www.amgen.ca/stories/2022/08/views-fracture-clinic 2025-02-14 always https://www.amgen.ca/stories/2022/05/kerry-brennan-shares-her-breast-cancer-story 2025-07-16 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/05/kerry-brennan-shares-her-breast-cancer-story 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2022/05/amgen-donates-medicines-to-tanzania-and-myanmar 2025-06-26 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/05/amgen-donates-medicines-to-tanzania-and-myanmar 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/05/hip-fracture-prevention-strategies-needed-to-help-reduce-fracture-risk-and-associated-costs 2025-04-28 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/05/hip-fracture-prevention-strategies-needed-to-help-reduce-fracture-risk-and-associated-costs 2025-04-29 daily 0.5 https://www.amgen.ca/stories/2022/05/on-the-future-of-science-learning 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/05/on-the-future-of-science-learning 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/amgen-scholars-a-biotechnology-launch-pad 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgen-scholars-a-biotechnology-launch-pad 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/03/expanding-therapeutic-options-for-canadians 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/expanding-therapeutic-options-for-canadians 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/giving-back-with-amgen-canada 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/giving-back-with-amgen-canada 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/how-amgen-works-to-find-the-answers-within 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/canadian-undergraduates-reflect-on-once-in-a-lifetime-amgen-scholars-opportunity 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/canadian-undergraduates-reflect-on-once-in-a-lifetime-amgen-scholars-opportunity 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/amgen-canada-covid-19-and-bone-health 2025-02-19 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgen-canada-covid-19-and-bone-health 2024-11-05 daily 0.5 https://www.amgen.ca/stories/2022/03/are-canadian-youth-prepared-for-the-workplace-of-tomorrow 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/are-canadian-youth-prepared-for-the-workplace-of-tomorrow 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/a-scorecard-for-osteoporosis-in-canada-and-seven-canadian-provinces 2024-11-04 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/a-scorecard-for-osteoporosis-in-canada-and-seven-canadian-provinces 2024-11-05 daily 0.5 https://www.amgen.ca/stories/2022/03/finding-stem-in-your-childs-future 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/finding-stem-in-your-childs-future 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/heart-month-2020-time-to-focus-on-cardiovascular-health 2025-09-23 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/heart-month-2020-time-to-focus-on-cardiovascular-health 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/03/how-abe-is-helping-an-award-winning-educator-nurture-lab-skills 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/how-abe-is-helping-an-award-winning-educator-nurture-lab-skills 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/how-a-canadian-gastroenterologist-talks-to-patients-about-biologic-and-biosimilar-drugs 2025-02-19 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/how-a-canadian-gastroenterologist-talks-to-patients-about-biologic-and-biosimilar-drugs 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/03/how-a-friendly-moose-helps-kids-understand-multiple-myeloma 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/how-a-friendly-moose-helps-kids-understand-multiple-myeloma 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/how-a-playful-lion-helps-kids-understand-multiple-myeloma 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/how-a-playful-lion-helps-kids-understand-multiple-myeloma 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/03/making-the-invisible-more-visible 2025-05-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/making-the-invisible-more-visible 2025-06-05 daily 0.5 https://www.amgen.ca/stories/2022/03/multiple-myeloma 2025-05-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/multiple-myeloma 2025-05-14 daily 0.5 https://www.amgen.ca/stories/2022/03/osteoporosis-prevention--little-things-and-bone-health 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/osteoporosis-prevention--little-things-and-bone-health 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/preparing-the-next-generation-of-stem-leaders-at-the-amgen-biotech-experience 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/preparing-the-next-generation-of-stem-leaders-at-the-amgen-biotech-experience 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/spotlight-on-science-learning 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/spotlight-on-science-learning 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/understanding-the-multiple-myeloma-journey 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/understanding-the-multiple-myeloma-journey 2025-02-14 daily 0.5 https://www.amgen.ca/stories/2022/03/8-tips-for-your-heart-health-journey-a-guide-for-heart-attack-survivors 2025-02-19 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/8-tips-for-your-heart-health-journey-a-guide-for-heart-attack-survivors 2025-02-21 daily 0.5 https://www.amgen.ca/stories/2022/03/accessing-the-medicines-best-for-you 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/accessing-the-medicines-best-for-you 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/break-records-not-bones-join-amgen 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/break-records-not-bones-join-amgen 2024-11-05 daily 0.5 https://www.amgen.ca/stories/2022/03/canadians-and-osteoporosis-the-latest-facts 2024-11-04 always https://www.amgen.ca/fr-ca/stories/2022/03/canadians-and-osteoporosis-the-latest-facts 2025-02-14 always https://www.amgen.ca/stories/2022/03/company-culture-nasopharyngeal-cancer 2025-04-28 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/company-culture-nasopharyngeal-cancer 2025-04-28 daily 0.5 https://www.amgen.ca/stories/2022/03/fracture-risk-and-mortality-following-a-fragility-fracture 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/fracture-risk-and-mortality-following-a-fragility-fracture 2024-11-05 daily 0.5 https://www.amgen.ca/stories/2022/03/meet-rebecca-hodgson 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/meet-rebecca-hodgson 2025-06-05 daily 0.5 https://www.amgen.ca/stories/2022/03/people-of-amgen-christy-thomson 2025-06-05 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/people-of-amgen-christy-thomson 2025-06-05 daily 0.5 https://www.amgen.ca/stories/2022/03/significant-gaps-remain-for-fracture-risk-calculation-and-osteoporosis 2025-09-10 always https://www.amgen.ca/fr-ca/stories/2022/03/significant-gaps-remain-for-fracture-risk-calculation-and-osteoporosis 2024-11-05 always https://www.amgen.ca/stories/2022/03/take-10-minutes-for-your-bone-health 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/take-10-minutes-for-your-bone-health 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/know-your-bones-like-you-know-your-breasts 2025-06-17 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/know-your-bones-like-you-know-your-breasts 2025-06-17 daily 0.5 https://www.amgen.ca/stories/2022/03/amgen-canada-colorectal-cancer 2025-06-05 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgen-canada-colorectal-cancer 2025-06-05 daily 0.5 https://www.amgen.ca/stories/2022/03/amgen-canada-participates-in-annual-cibc-run-for-the-cure 2024-11-03 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgen-canada-participates-in-annual-cibc-run-for-the-cure 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/amgen-scholars-science-learning-for-the-next-generation-of-stem-leaders 2025-09-10 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgen-scholars-science-learning-for-the-next-generation-of-stem-leaders 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2022/03/transforming-science-education-for-lifelong-learning-and-opportunity 2025-06-16 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/transforming-science-education-for-lifelong-learning-and-opportunity 2025-05-29 daily 0.5 https://www.amgen.ca/stories/2022/03/amgens-biotechnology-leadership 2025-02-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/amgens-biotechnology-leadership 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2022/03/how-to-get-a-fit-test-for-colorectal-cancer-in-canada 2025-02-21 daily 0.5 https://www.amgen.ca/fr-ca/stories/2022/03/how-to-get-a-fit-test-for-colorectal-cancer-in-canada 2024-11-01 daily 0.5 https://www.amgen.ca/stories/2023/03/people-of-amgen-what-makes-being-an-msl-rewarding-for-kim-chan 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/03/people-of-amgen-what-makes-being-an-msl-rewarding-for-kim-chan 2025-07-16 daily 0.5 https://www.amgen.ca/stories/2023/05/steves-colorectal-cancer-journey 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/05/steves-colorectal-cancer-journey 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2023/06/episode1 2024-11-03 daily 0.5 https://www.amgen.ca/stories/2023/06/episode2 2024-11-03 daily 0.5 https://www.amgen.ca/stories/2023/06/episode3 2024-11-03 daily 0.5 https://www.amgen.ca/stories/2023/06/episode4 2024-11-03 daily 0.5 https://www.amgen.ca/stories/2023/06/episode5 2024-11-03 daily 0.5 https://www.amgen.ca/stories/2023/08/cvd-patient 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/08/cvd-patient 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2023/08/keeping-our-cholesterol-levels-in-check 2025-05-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/08/keeping-our-cholesterol-levels-in-check 2025-05-02 daily 0.5 https://www.amgen.ca/stories/2023/11/hip-fracture 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/11/hip-fracture 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2023/11/spine-fracture 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2023/11/spine-fracture 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2024/02/people-of-amgen-bc-timin-hadi 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2024/02/people-of-amgen-bc-timin-hadi 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2024/02/people-of-amgen-bc-chris-murawsky 2025-05-14 daily 0.5 https://www.amgen.ca/fr-ca/stories/2024/02/people-of-amgen-bc-chris-murawsky 2025-05-14 daily 0.5 https://www.amgen.ca/stories/2024/02/people-of-amgen-bc-desiree-lim 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2024/02/people-of-amgen-bc-desiree-lim 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2024/11/discover-paulines-journey-with-osteoporosis 2025-06-06 daily 0.5 https://www.amgen.ca/fr-ca/stories/2024/11/discover-paulines-journey-with-osteoporosis 2025-06-06 daily 0.5 https://www.amgen.ca/stories/2024/11/ongoing-care-for-high-risk-cardiac-patients 2025-08-12 daily 0.5 https://www.amgen.ca/fr-ca/stories/2024/11/ongoing-care-for-high-risk-cardiac-patients 2025-08-07 daily 0.5 https://www.amgen.ca/stories/2025/02/a-patients-journey-to-nmosd-diagnosis 2025-02-28 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/02/a-patients-journey-to-nmosd-diagnosis 2025-02-28 daily 0.5 https://www.amgen.ca/stories/2025/02/the-importance-of-early-diagnosis 2025-05-19 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/02/the-importance-of-early-diagnosis 2025-02-28 daily 0.5 https://www.amgen.ca/stories/2025/03/importance-early-screening-steve-story 2025-04-25 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/03/importance-early-screening-steve-story 2025-04-28 daily 0.5 https://www.amgen.ca/stories/2025/03/managing-cholesterol-after-a-heart-attack-or-stroke 2025-04-02 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/03/managing-cholesterol-after-a-heart-attack-or-stroke 2025-04-24 daily 0.5 https://www.amgen.ca/stories/2025/03/understanding-nmosd-the-importance-of-early-diagnosis 2025-03-25 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/03/understanding-nmosd-the-importance-of-early-diagnosis 2025-03-24 daily 0.5 https://www.amgen.ca/stories/2025/03/why-lowering-cholesterol-after-a-heart-attack-is-crucial 2025-03-26 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/03/why-lowering-cholesterol-after-a-heart-attack-is-crucial 2025-03-26 daily 0.5 https://www.amgen.ca/stories/2025/06/what-claudie-has-learned-living-with-cancer 2025-07-08 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/06/what-claudie-has-learned-living-with-cancer 2025-07-08 daily 0.5 https://www.amgen.ca/stories/2025/08/the-rare-disease-journey 2025-07-29 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/08/the-rare-disease-journey 2025-07-29 daily 0.5 https://www.amgen.ca/stories/2025/08/reducing-the-risk-of-a-second-heart-attack-starts-with-recovery 2025-12-23 daily 0.5 https://www.amgen.ca/fr-ca/stories/2025/08/reducing-the-risk-of-a-second-heart-attack-starts-with-recovery 2025-08-21 daily 0.5 https://www.amgen.ca/stories/2026/02/rick-bragas-high-cholesterol-his-wakeup-call-and-the-turning-point 2026-01-30 daily 0.5 https://www.amgen.ca/fr-ca/stories/2026/02/rick-bragas-high-cholesterol-his-wakeup-call-and-the-turning-point 2026-01-30 daily 0.5 https://www.amgen.ca/stories/2026/03/how-sumaira-turned-her-rare-disease-into-a-vision-for-a-global-cause 2026-02-24 daily 0.5 https://www.amgen.ca/fr-ca/stories/2026/03/how-sumaira-turned-her-rare-disease-into-a-vision-for-a-global-cause 2026-02-23 daily 0.5 https://www.amgen.ca/media/press-releases/2025/03/enhanced-cardiovascular-care-available-to-new-brunswick-patients-thanks-to-horizon-amgen-canada-research-partnership 2025-03-13 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2025/03/enhanced-cardiovascular-care-available-to-new-brunswick-patients-thanks-to-horizon-amgen-canada-research-partnership 2025-03-13 monthly 1.0 https://www.amgen.ca/media/press-releases/2024/01/amgen-british-columbia-completes-state-of-the-art-lab-expansion 2024-03-14 monthly 1.0 https://www.amgen.ca/media/press-releases/2024/03/nine-drug-formularies-in-canada-list-evenity 2024-03-14 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2024/03/nine-drug-formularies-in-canada-list-evenity 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2024/03/wezlana-ustekinumab-a-biosimilar-to-stelara-now-available-in-canada-for-certain-chronic-inflammatory-diseases 2024-03-14 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2024/03/wezlana-ustekinumab-a-biosimilar-to-stelara-now-available-in-canada-for-certain-chronic-inflammatory-diseases 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2024/09/a-million-discoveries-how-the-amgen-biotech-experience-shapes-future-innovators 2024-09-10 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2024/09/a-million-discoveries-how-the-amgen-biotech-experience-shapes-future-innovators 2024-09-10 monthly 1.0 https://www.amgen.ca/media/press-releases/2023/01/amgen-establishes-a-corporate-lab-at-mila 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2023/01/amgen-establishes-a-corporate-lab-at-mila 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2023/06/innovative-partnership 2023-06-06 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2023/06/innovative-partnership 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2023/11/health-canada-has-granted-full-approval-for-blincytoin-adult-and-pediatric-patients 2023-11-09 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2023/11/health-canada-has-granted-full-approval-for-blincytoin-adult-and-pediatric-patients 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2022/01/canadian-study-reinforces-need-for-hip-fracture-prevention 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2022/01/canadian-study-reinforces-need-for-hip-fracture-prevention 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2022/10/tezspire-tezepelumab-injection--now-available-in-canada-for-severe-asthma 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2022/10/tezspire-tezepelumab-injection--now-available-in-canada-for-severe-asthma 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/02/amgen-presents-results-from-phase-2-cohort-of-codebreak-100-clinical-study 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/02/amgen-presents-results-from-phase-2-cohort-of-codebreak-100-clinical-study 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/03/amgen-announces-artificial-intelligence-partnership-with-mila 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/03/amgen-announces-artificial-intelligence-partnership-with-mila 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/03/identification-and-management-of-osteoporotic-fractures 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/03/identification-and-management-of-osteoporotic-fractures 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/04/ccrm-and-amgen-partner-to-advance-emerging-medical-innovations 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/04/ccrm-and-amgen-partner-to-advance-emerging-medical-innovations 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/05/amgen-canada-today-announced-that-amgevita 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/05/amgen-canada-today-announced-that-amgevita 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/09/health-canada-approves-lumakras 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/09/health-canada-approves-lumakras 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2021/11/significant-gaps-remain-for-fracture-risk-calculation-and-osteoporosis-management 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2021/11/significant-gaps-remain-for-fracture-risk-calculation-and-osteoporosis-management 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/12/new-study-gives-canada-a-b-grade-for-overall-cancer-mortality 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/12/new-study-gives-canada-a-b-grade-for-overall-cancer-mortality 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/11/amgen-canada-launches-my-heartpath 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/11/amgen-canada-launches-my-heartpath 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/10/new-scorecard-reveals-critical-need-to-make-osteoporosis-a-national-health-priority 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/10/new-scorecard-reveals-critical-need-to-make-osteoporosis-a-national-health-priority 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/09/clinical-data-from-full-phase-1-cohort-of-investigational-sotorasib-published-in-new-england-journal-of-medicine 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/09/clinical-data-from-full-phase-1-cohort-of-investigational-sotorasib-published-in-new-england-journal-of-medicine 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/04/amgen-canada-launches-$1m-giving-program-to-support-canadians-during-covid-19 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/04/amgen-canada-launches-$1m-giving-program-to-support-canadians-during-covid-19 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/02/amgen-canada-receives-approval-of-marketing-authorization-transfer-of-otezla 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/02/amgen-canada-receives-approval-of-marketing-authorization-transfer-of-otezla 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2020/02/survivors-in-canada-are-taking-steps-to-reduce-the-risk-of-another-heart-attack--but-is-it-enough 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2020/02/survivors-in-canada-are-taking-steps-to-reduce-the-risk-of-another-heart-attack--but-is-it-enough 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/10/health-canada-approves-evenity 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/09/toronto-innovation-acceleration-partners-announces-strategic-partnership-with-amgen 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/06/amgen-highlights-the-versatility-of-the-bite-immuno-oncology-platform-in-multiple-tumor-types-at-asco-2019 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/06/amgen-highlights-the-versatility-of-the-bite 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2019/06/amgen-highlights-the-versatility-of-the-bite 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/06/amgen-and-takeda-join-the-quantum-leap-project-led-by-cqdm 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2019/06/amgen-and-takeda-join-the-quantum-leap-project-led-by-cqdm 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/06/amgen-announces-first-clinical-data-evaluating-investigational-kras 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2019/06/amgen-announces-first-clinical-data-evaluating-investigational-kras 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/05/amgen-invites-the-general-public-to-help-set-an-official-guinness-world-records 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2019/05/amgen-sets-official-guinness-world-record-for-most-osteoporosis-screenings-in-24-hours 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2018/11/university-of-toronto-mississauga-and-local-teachers-bring-transformative-biotechnology-education 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2018/11/university-of-toronto-and-amgen-foundation-partner 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2018/11/amgen-becomes-a-new-member-of-cqdm-to-further-the-development-of-cutting-edge-drug-discovery 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2018/10/transforming-science-education-in-ontario 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2018/06/health-canada-approves-amgens-repatha 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2017/12/amgen-canada-expands-its-support-for-stem-learning-initiatives-for-canadian-youth 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2017/04/new-medication-for-high-risk-populations 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2017/03/new-cardiovascular-outcomes-study 2025-02-20 monthly 1.0 https://www.amgen.ca/media/press-releases/2016/11/health-canada-approves-amgens-new-multiple-myeloma 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2016/11/health-canada-approves-amgens-new-multiple-myeloma 2024-07-02 monthly 1.0 https://www.amgen.ca/media/press-releases/2016/01/health-canada-approves-amgens-new-multiple-myeloma 2025-02-20 monthly 1.0 https://www.amgen.ca/fr-ca/media/press-releases/2016/01/health-canada-approves-amgens-new-multiple-myeloma 2024-07-02 monthly 1.0